P 2022

4-(1H-imidazol-5-yl)-1H-pyrrolo[2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors

BRYJA, Vítězslav, Pavlína JANOVSKÁ, Michaela GREGOROVÁ, Václav NĚMEC, PrashantKumar KHIRSARIYA et. al.

Basic information

Original name

4-(1H-imidazol-5-yl)-1H-pyrrolo[2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors

Authors

BRYJA, Vítězslav (203 Czech Republic, belonging to the institution), Pavlína JANOVSKÁ (203 Czech Republic, belonging to the institution), Michaela GREGOROVÁ (203 Czech Republic, belonging to the institution), Václav NĚMEC (203 Czech Republic, belonging to the institution), PrashantKumar KHIRSARIYA (356 India, belonging to the institution) and Kamil PARUCH (203 Czech Republic, belonging to the institution)

Edition

Number: US11498920, Publisher: United States Patent and Trademark Office, Place of publication: Alexandria, Virginia, Owner's name: Masarykova univerzita, 2022

Other information

Language

English

Type of outcome

Patent

Field of Study

10401 Organic chemistry

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

RIV identification code

RIV/00216224:14310/22:00128923

Organization unit

Faculty of Science

Keywords in English

lymphomas; leukaemia; solid tumors

Tags

Změněno: 22/3/2023 13:35, Mgr. Marie Šípková, DiS.

Abstract

V originále

Novel 4-(1H-imidazol-5-yl)-1H-pyrrolo[2,3-b]pyridine compounds that are useful in the treatment of lymphomas, leukaemias, and solid tumors.